A Phase 2 study of SYHA1813 in high-grade meningioma
Not Yet Recruiting Phase 2 NCT06739213
Study Description
A study evaluating the effectiveness and safety of an experimental drug called SYHA1813 compared to standard treatment in patients with recurrent or progressive high-grade meningioma
Study Details
- Registry ID:
- NCT06739213
- Conditions:
- Recurrent or Progressive High Grade Meningioma
- Phase:
- Phase 2
- Target Enrollment:
- 56 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.